Reuter U, Goadsby PJ, Ferrari MD, Da Silva Lima GP, et al. Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed: LIBERTY 3-Year Study. Neurology 2024;102:e209349.
PMID: 38669638